4CPS-101 Biologic agents in rheumatological diseases: impact of ‘treat to target’ in clinical practice
Background and importanceThe aim of rheumatological diseases (RD) treatment should be clinical remission (CR) or alternatively a state of low level of clinical activity. The treatment of RD with a ‘treat to target’ (T2T) strategy consists of measuring and recording disease activity at each visit. If...
Gespeichert in:
Veröffentlicht in: | European journal of hospital pharmacy. Science and practice 2022-03, Vol.29 (Suppl 1), p.A61-A62 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!